Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy have?
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy has 605 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy published?
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy has 2019 year in the ScholarIQ index.
What is the open-access status of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy has bronze oa status in the ScholarIQ index.
What is the DOI of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?
The DOI for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is on the source record.
What is the PMID of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?
The PMID for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is on the source record.
What is the OpenAlex record for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy?
The OpenAlex for Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy is on the source record.